The last breath for inhaled antibiotics and VAP? Not so fast

Lancet Infect Dis. 2020 Mar;20(3):265-266. doi: 10.1016/S1473-3099(19)30690-5. Epub 2019 Dec 19.

Authors

Daniel A Sweeney¹, Andre C Kalil²

Affiliations

¹ Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, University of California, San Diego, CA, USA.
² Division of Infectious Diseases, Department of Medicine, University of Nebraska Medical Center, Omaha, NE 68135, USA. Electronic address: akalil@unmc.edu.

PMID: 31866325
DOI: 10.1016/S1473-3099(19)30690-5

No abstract available

Publication types

Comment

MeSH terms

Amikacin
Anti-Bacterial Agents
Double-Blind Method
Humans
Pneumonia, Bacterial*
Pneumonia, Ventilator-Associated*
Respiration, Artificial

Substances

Anti-Bacterial Agents
Amikacin